Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Quadruple Hit Lymphoma: A Rare Entity with Dismal Prognosis

Jonathan Proulx, MD, Ryan Denley, DO, Bader Maria Pedemonte, MD, Ashish A. Shah, DO, Rachel Ochs, MD, Missak Haigentz, Jr., MD, Angela T. Alistar, MD, Ellen Early, MD, Eric D Whitman, MD, Mohamad Cherry, MD MS

Blood (2018) 132 (Supplement 1): 5305.

https://doi.org/10.1182/blood-2018-99-120147

Published: 2018

Journal Articles

Impact of Duration of Neutropenia and Lymphopenia on AML Patients Undergoing Induction Chemotherapy

Madiha Iqbal, MD, Minh Phan, MD, Michael Machiorlatti, MS, Sara K. Vesely, PhD, Jordan M Morton, MD, Jennifer Holter, MD, Mohamad Cherry, MD

Blood (2016) 128 (22): 5178.

https://doi.org/10.1182/blood.V128.22.5178.5178

Published: 2016

Journal Articles

Prognostic Significance of Weight Loss and BMI during Induction Chemotherapy of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients

Zachary Smith, MD, Gabriel Vidal, MD, Michael Machiorlatti, MS, Sara K. Vesely, PhD, Summer Frank, MPH, Adam S. Asch, MD, Jennifer L Holter-Chakrabarty, MD, Mohamad Khawandanah, MD, Mohamad Cherry, MD

Blood (2015) 126 (23): 5625.

https://doi.org/10.1182/blood.V126.23.5625.5625

Published: 2015

Journal Articles

Analysis of Outcome of Patients with Acute Myeloid Leukemia According to Socio-Economic Status

Namali Pierson, MD, Shawn Chaudry, MPH, Gabriel Vidal, MD, Michael Machiorlatti, MS, Summer Frank, MPH, Sara K. Vesely, PhD, James K. Feisal, MD, Samer A Srour, MB ChB, MS, Mohammad O. Khalil, MD, Alexandra Ikeguchi, MD, Mohamad Khawandanah, MD, Mohamad Cherry, MD

Blood (2015) 126 (23): 5627.

https://doi.org/10.1182/blood.V126.23.5627.5627

Published: 2015

Journal Articles

Further Evidence to Not Delay Transplant for Continued ARA-C Consolidation in Patients with Intermediate or High Risk AML

James K. Feisal, MD, Nicholas B. Pleat, DO, Michael Machiorlatti, MS, Summer Frank, MPH, Sara Vesley, PhD, Sarah Schmidt, PharmD, George Selby, MD, Carrie Yuen, MD, Jennifer L Holter-Chakrabarty, MD, Mohamad Cherry, MD, Mohamad Khawandanah, MD

Blood (2015) 126 (23): 5544.

https://doi.org/10.1182/blood.V126.23.5544.5544

Published: 2015

Journal Articles

Combination Trial of Duvelisib (IPI-145) with Bendamustine, Rituximab, or Bendamustine/Rituximab in Patients with Lymphoma or Chronic Lymphocytic Leukemia

Ian W. Flinn, MD PhD, Mohamad Cherry, MD, Michael Maris, MD, Jeffrey V. Matous, MD, Jesus G. Berdeja, MD, Manish R. Patel, MD

Blood (2015) 126 (23): 3928.

https://doi.org/10.1182/blood.V126.23.3928.3928

Published: 2015

Journal Articles

Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

Bilal Ahmad, MD, Hossein Maymani, MD, Haseeb Saeed, MD, Mohamad Khawandanah, MD, Samer A Srour, MB ChB, Michael G Machiorlatti, MS, Adam S. Asch, MD, Mohamad Cherry, MD

Blood (2014) 124 (21): 2274.

https://doi.org/10.1182/blood.V124.21.2274.2274

Published: 2014

Journal Articles

An Open-Label, Phase Ib Study of Duvelisib (IPI-145) in Combination with Bendamustine, Rituximab or Bendamustine/Rituximab in Select Subjects with Lymphoma or Chronic Lymphocytic Leukemia

Ian Flinn, Manish R. Patel, MD, Michael B Maris, MD, Jeffrey Matous, MD, Mohamad Cherry, MD, Jesus G. Berdeja, MD

Blood (2014) 124 (21): 4422.

https://doi.org/10.1182/blood.V124.21.4422.4422

Published: 2014

Journal Articles

Time from Hospital Admission to Induction Chemotherapy Adversely Affects Outcomes in Patients with Acute Myeloid Leukemia

Hossein Maymani, MD, Bilal Ahmad, MD, Michael G Machiorlatti, MS, Sara K. Vesely, PhD, Samer A Srour, MB ChB, George Selby, MD, Adam S. Asch, MD, Mohamad Cherry, MD

Blood (2014) 124 (21): 1289.

https://doi.org/10.1182/blood.V124.21.1289.1289

Published: 2014

Journal Articles

Western Intravascular Lymphoma (IVL): Case Series of Published Reports Between 1994-2014

Mohamad Khawandanah, MD, Bilal Ahmad, MD, Fahad Khan, MD, Jennifer L. Holter Chakrabarty, MD, Carrie Yuen, MD, George Selby, MD, Adam S. Asch, MD, Mohamad Cherry, MD

Blood (2014) 124 (21): 5417.

https://doi.org/10.1182/blood.V124.21.5417.5417

Published: 2014

Journal Articles

Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia– a Systematic Review of Cases Reported in the Literature

Sonia John, MD, Mohammed Abdul Muqeet Adnan, MD, Mohammad O. Khalil, MD, George Selby, MD, Adam S. Asch, MD, Mohamad Cherry, MD, Mohamad Khawandanah, MD

Blood (2014) 124 (21): 3694.

https://doi.org/10.1182/blood.V124.21.3694.3694

Published: 2014

Journal Articles

Analysis Of Impact Of Distance From Residence To Treatment Center On The Outcome Of Patients With Acute Myeloid Leukemia

David W. Lam, MD, Hossein Maymani, MD, Michael G Machiorlatti, MS, Samer A Srour, MB ChB, Minh Phan, MD, George Selby, MD, Jennifer L. Holter, MD, Mohamad Cherry, MD

Blood (2013) 122 (21): 1712.

https://doi.org/10.1182/blood.V122.21.1712.1712

Published: 2013

Journal Articles

Predictors Of Cancer Associated Thrombosis

Alfonso Tafur, MD, RPVI, George L. Dale, PhD, Suman Rathbun, MD, Aaron S. Mansfield, MD, Mohamad Cherry, MD, Philip C. Comp, MD, PhD, Jonathan Wren, PhD, Julie Stoner, PhD

Blood (2013) 122 (21): 3616.

https://doi.org/10.1182/blood.V122.21.3616.3616

Published: 2013

Journal Articles

Acute Myeloid Leukemia: Pretreatment Biochemical and Clinical Variables Predictive For Risk Status Based On Validated Cytogenetic and Molecular Abnormalities

Samer A Srour, MB ChB, Michael G Machiorlatti, MS, Mohamad Cherry, MD, Namali Pierson, MD, Usman Z Bhutta, MD, David M Thompson, Ph.D., P.T., Carla D Kurkjian, MD

Blood (2013) 122 (21): 4962.

https://doi.org/10.1182/blood.V122.21.4962.4962

Published: 2013

Journal Articles

Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera

Mohamad Cherry, MD, Mohamad Khawandanah, MD, Zhizhuang Joe Zhao, Samer A Srour, MB ChB, Howard Ozer, MD, PhD, George Selby, MD, Bassam Ghabache, MD, Aref Al-Kali, MD

Blood (2013) 122 (21): 1597.

https://doi.org/10.1182/blood.V122.21.1597.1597

Published: 2013

NARROW

Quadruple Hit Lymphoma: A Rare Entity with Dismal Prognosis

Impact of Duration of Neutropenia and Lymphopenia on AML Patients Undergoing Induction Chemotherapy

Prognostic Significance of Weight Loss and BMI during Induction Chemotherapy of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients

Analysis of Outcome of Patients with Acute Myeloid Leukemia According to Socio-Economic Status

Further Evidence to Not Delay Transplant for Continued ARA-C Consolidation in Patients with Intermediate or High Risk AML

Combination Trial of Duvelisib (IPI-145) with Bendamustine, Rituximab, or Bendamustine/Rituximab in Patients with Lymphoma or Chronic Lymphocytic Leukemia

Impact of Insurance Status on the Day of Admission and Clinical Outcome on Acute Myeloid Leukemia (AML)Patients

An Open-Label, Phase Ib Study of Duvelisib (IPI-145) in Combination with Bendamustine, Rituximab or Bendamustine/Rituximab in Select Subjects with Lymphoma or Chronic Lymphocytic Leukemia

Time from Hospital Admission to Induction Chemotherapy Adversely Affects Outcomes in Patients with Acute Myeloid Leukemia

Western Intravascular Lymphoma (IVL): Case Series of Published Reports Between 1994-2014

Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia– a Systematic Review of Cases Reported in the Literature

Analysis Of Impact Of Distance From Residence To Treatment Center On The Outcome Of Patients With Acute Myeloid Leukemia

Predictors Of Cancer Associated Thrombosis

Acute Myeloid Leukemia: Pretreatment Biochemical and Clinical Variables Predictive For Risk Status Based On Validated Cytogenetic and Molecular Abnormalities

Erlotinib Is Not Effective In Patients (Pts) With JAK-2 V617F Positive Polycythemia Vera

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only